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Activation of T lymphocytes by antigen-presenting 
cells requires the interaction of major histocompati-
bility complex/antigen complexes with the T -cell 
receptor as well as the binding of co-stimulatory 
molecules to receptors on T cells. Freshly isolated 
epidermal Langerhans cells (LC) do not display a 
significant number of co-stimulatory molecules. 
After short-term culture, LC express and then up-
regulate intercellular adhesion molecule-1 (ICAM-1) 
(CD54), leukocyte function-associated antigen (LFA)-
3 (CD58), and B7-1 (CDSO) accessory molecules and 
exhibit an enhanced antigen-presenting function. The 
present study examined the presence on human LC 
of the LFA-1 ligands ICAM-2 (CD102) and ICAM-3 
(CD50) and their functional role in the activation of 
allogeneic T cells. Immunohistochemistry of skin 
sections and flow-cytometry analysis of freshly pro-
cured epidermal cell suspensions showed that LC 
A ntigen-presenting cells (APC) need to supply two diffe rent se ts of signals to ac tivate T lymphocytes; major histocompatibility complex (MHC)-peptide complexes that interact with the T -cell receptor and accessory signals. These functions are provided by 
molecules present on the APC m embrane that bind to receptors on 
the T-cell surface, allowing intimate physical contac t between APC 
and T cells (adhesion molecules) and transmitting additional acti-
va tion signals [1-4]. Co-stimulation is especially critical for activa-
tion of resting and naive T cells; indeed, engagem ent of the T - cell 
receptor in the absence of co-stimulation may lead to long-lastin g 
functional impairment of n aive T cells (an ergy) [5]. 
D endritic cells (DC) , including epidermal La.nge rhans cells (LC), 
are the most e ffective activa tors of naive T lymphocytes and appear 
to b e cm cial in the induction of primary T - cell-mediated immune 
responses [ 6, 7] . This property has been attributed, at least in part, 
to the constitutive expression of high levels of MHC and various 
accessory molecules [7) . Freshly isola ted LC (tl.C) do not display 
significant numbers of membrane co-stiJnulatory m o lecules and are 
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(CD1a + or HLA-DR +) expressed ICAM-3 but not 
ICAM-2. After 48-72-h culture in the presence of 
granulocyte/macrophage colony-stimulating factor, 
LC did not stain for ICAM-2 but expressed ICAM-3 at 
the same level as fresh cells. Incubation of both 
freshly isolated and cultured LC with monoclonal 
antibodies directed against ICAM-3 reduced T -cell 
proliferation (25-75% inhibition) in the primary allo-
geneic mixed leukocyte reaction assay; incubation of 
cultured LC with anti-ICAM-1 and anti-ICAM-3 syn-
ergistically reduced T -cell response. The results in-
dicate that ICAM-3 is constitutively expressed an4 
represents an important costimulatory molecule on 
freshly isolated LC but, in contrast to other accessory 
molecules, is not subjected to regulation during LC 
culture. Key words: atttigett-presentit~g cells/dettdritic cells/ 
co-stirmtlatory molecules IT-cell activatiott. J Ittvest Dertttatol 
105:215-219, 1995 
not very efficient APC. However, during short-term culture, LC 
(cLC) undergo an activation process b y upregulating expression of 
MHC and co-stimulatory molecules and m arkedly increasing their 
antigen-presenting capacity [6 ,8 -11). 
R ecently, two new m embers of the Ig superfanllly of receptors, 
the inte rcellular adhesion molecule (ICAM)-2 (CD1 02) and 
ICAM-3 (CDSO), have been added to the list of adhesion/costimu-
latory molecules present on leukocytes [12-18]. In addition, 
ICAM-3 , but not ICAM-2 , has been detected on LC in sections of 
human epide rmis (19]. In tllis study, we examined the functional 
expression of ICAM-2 and ICAM-3 on human LC and tl1eir 
possible regulation during culture . 
MA TER!ALS AND METHODS 
Monoclonal Antibodies (MoAbs) Details of the murine MoAbs used in 
this study are b.-iven in Table I. 
Staining of Skin Sections Frozen 4-6-JJ.m thick sections from normal 
adult skin were processed for immunohistochemistry using a three-step 
avidin-biotin-peroxidase technique, as previously described [1 0]. Primary 
MoAbs were anti-CDla (OKT6). anti-ICAM-2 (CBR-IC2/l, CBR-
!C2/2, 6D5) and anti-ICAM-3 (BR!C79, TPl/24 , 152-2D11). Control 
samples were incubated with irrelcvru1t matched isotype MoAb. 
Epidermal Cell Suspensions and LC Enrichment· Skin obtained from 
adult patients lUldergoing plastic sm gery was keratomized, cut into small 
pieces, and floated in 0.5% dispase (Neutral protease grade Il , Boehringer 
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Table I. Monoclonal Antibodies 
Specificity C lone lsorypc Form Source'' 
COla OKT6 lgG1 Purified OD 
HLA- DR L243 lgG l Purified BD 
ICAM-1 Rl"t1 lgG l Purified Springer [20]1' 
JCAM-2 CB K-I C2/1 lgG2a Purifi ed de Fougero lles [1 2t 
ICAM-2 C BR-IC2/2 lgG2a Purified de Fougerolles (1 2r' 
ICAM-2 605 lgGl Purified Gahrnberg [21 r ' 
JCAM-3 CBR-IC3/ l lgG'I Ascites de Fuugt:.-oll t:s [22r' 
l.CAM-3 CBR-IC3/3 lgG2a Purified de Fougcrollcs [23]1' 
IC AM-3 KS128 lgG1 Ascites T urley [24r' 
ICAM-3 CG106 lgG Asc ites Cordell [24r ' 
ICAM-3 BRJC79 lgG2a Purified Anstee [25r ' 
ICAM-3 TPl/24 l gG2a Ascites S:\nchez-Madrid [1 9t 
JCAM-3 l-IJJZ/19 IgG2a Ascites Sanchez-Madrid [1 8]1' 
ICA M-3 152-2011 lgG1 Ascites Vilella [1 6]1' 
Controls: 
{34 integrin 3El IgG1 Ascites TP 
CDS SK1 lgG2a Purified BD 
11 OD. O nho Diagnostic System, R:~ri til n, N.J ; 130, Dccton Dickinson, Sa n Jose, CA; TP. Tclios Ph an11aceutic;Ji s. San Diego. CA. 
11 Obtained from the 5th ln tcn1 ationnl Workslmp o n Human Leukocyte Differentiation Anligcns (Boston , MA. N ovembe r 3-7, '1. 993). 
Mannheim, Mannheim, German y) fo r 60 min at 37°C. T he epidermis was 
then separated from the dermis, and single ce ll suspensions were prepared 
by trypsinization (0.25'X. for 20 min at 37°C), as described elsewhere (9]. To 
enrich fo r LC, epidermal ce ll suspensions were allowed to adhere in 
collagen-coated culture dishes. After 90 min, the non-adherent fraction was 
co llected, vo rtexed for 1 Jl1in in cold hypotonic so lu tion [8:2 phosphate-
buffered s.1 line (PBS)/ di stilled water] and then subjected to density gradient 
centrifugation using Ficoii-Paque (1.077 g/ml) (Pharmacia, Uppsala, Swe-
den). Cells fro m the interf:1 ce were harvested and washed in Dulbecco's 
modified Eagle's medium (DMEM) [9]. Cell viability was estimated by 
trypan blue exclusion to range from 85 to 95'X>. T hese interface epidermal 
cell s routine ly con tain ed 'I S-401Xl LC. a.s assessed by positive staining with 
anti-CD1 a MoAb and evaluation by fluorescence microscopy or A ow 
cytometry. 
Epidermal CeU Cultures Epidermal ce ll suspensions enriched for LC as 
described above were cultured in KPMI 1640 supplemented with heat-
inactivated 'I O'X. feta l bovine serum (FBS) , 25 mM HEPES, 0.1 mM 
non-essential amino acids, 2 mM L-glutamine, l mM sodium pyruvate (all 
Biochrom KG, BerLin , Gennany), 0.05 mM 2-mercaptoethanol (Merck, 
Darmstadt, GenTJany), l OU U/ml penici llin , and 100 f.tg/ ml streptomycin 
(Bioch.rom) (complete medium) at 3rC with 5% C02 • In most experi-
ments, 200 ng/m l human recombinant granulocyte/macrophage colony-
stimulating factor (gift of Dr. G. Corbctta , Sandoz, Italy) was added to 
improve LC surv ival. The viabi.li ry of cells after cul tu re ranged from 60 to 
70i%. 
Immunofluorescent CeU Labeling DM.EM supplemented with 1 () 
mM HEPES and l 'X, FBS was used to wash ce lls and dilu te anti bodies. 
Freshly isolated or cul tured epidermal ce lls enriched for LC were incubated 
with the anti-ICAM-3 or anti-ICAM-2 MoAbs for 30 min on ice and then 
with phycoerythrin-conjugated goat anti-mouse Ig (Dakopatts, Copenha-
gen, Denmark) for 30 min. After incubation with 5% normal mouse serum 
for I 0 min , ce lls were stained with fluorescein isothiocyanate- conjugatcd 
anti-HLA-DK (2.5 J.Lg/ml) or anti-COl a (2.5 f.tg / ml). In control samples, 
the primary MoAb was omitted or substituted wi th a malched isotype 
control. Cells were evaluated with a FACScan equipped with Lysys 1.1 
software (Becton Dicki11son). 
Mixed Leukocyte Reaction (MLR) Freshly iso lated or 48-h cultured 
epidermal cells (1500-3000 LC/well) were incubated with the dialyzed 
MoAbs of interest in Ant-bottomed microwell s at 4°C for 60 min. FoLlowing 
cell washing, 1.5 X 1.0 5 allogeneic T ce ll s (non-adherent peripheral blood 
mononucle;n· cells) were added and placed at 37°C for the period of culture. 
As a control, epidermal cel.l s were left either untreated or incubated with 
matched isotype controls. Co-cultures were carried out in complete me-
dium conta in ing 5% auto logous plasma instead of FIJS. T -cell proliferation 
was measured 5 d later by incorporation of l fLCi /well of l3 1-1] thymidiJ1e (82 
C i/ mM; Amcrsham, UK) for 14-16 h. Radioactivity ,.;as measured in a 
Minaxi Tri-Carb counter (Packard, Meriden, CT). Results arc expressed as 
the mean cpm :':: SD of triplica te measurements. Experiments were repeated 
at least three times w ith similar resu lts. 
RESULTS 
LC In Situ and tLC in Suspension Express ICAM-3 But Not 
ICAM-2 We confirme d b y immuno histoch e mistry that e pide r-
mal d endri tic CDla + cells i11 situ lack ICAM-2 but express abun-
d ant ICAM-3 (not shown) (19]. Two- color Aow-cytom etry analysis 
of fresh ly procure d LC-enriched e pide rmal cell suspensions re-
vealed that all CD1a + express ICAM-3 (Fig 1), thus indicating that 
ICAM-3 is not trypsin sensitive. Identi ca l res ults were obtaine d 
using different anti-ICAM-3 MoAbs (BR.IC79, TP1/24, CB R.-
IC3/1). In contrast, no ICAM-2 was detected on fLC (not shown) 
[11 ,26). 
ICAM-3 Expression on LC Is Not Regulated During Culture 
ln the followin g ex periments, we examined w heth e r ICAM-3 and 
ICAM-2 expression is subjected to regula tion during LC c ulture. 
Figure 1 shows that cLC (HLA-DR +) remained ICAM-2 n egati ve 
and expressed IC AM-3. To compare ICAM-3 expression in fLC 
and cLC, we conve rte d fluorescen ce inte n sities from a logarithmic 
to a linear sca le, as logarithmic data do not show the respective 
iJlte nsity of sa mples direc tly . A mathe matical mode l has been 
described for 256-chaJmcl Aow cytometries that allows the calcu-
lati.on of the true inte nsity re lationship betw een samples [27] , and 
this method was applie d to a 1 024-channe l Aow cytometer. As 
shown in Fig 2, m embrane ICAM-3 levels w e re similar in fLC and 
72-h c ul ture d LC. On the other hand, CDla or HLA-DR mole-
cul es respective ly decreased or augmente d during culture [28) . 
ICAM-3 Provides Co-Stimulation for Activation of Alloge-
neic T Cells To dete rmine the re levance of ICAM-3 to the A PC 
fm1 ctio n of LC, we studie d the effects of adding MoAbs against 
ICAM- 3 on the ability of both fLC and cLC to stimulate allogeneic 
T cells in a primary MLR assay. As shown in Fig 3 , MoAbs again st 
ICAM-3 inhibite d T - cell prolife ration induced by both fLC and 
cLC. The degree of inhibition varied according to the M oAb use d 
and ranged from 25 to 75%. No correlation was found b e twee n the 
ICAM-3 e pitope recognized and the degree of inhibition . BR.IC79 
was shown to be the most poten t anti-ICAM- 3 MoAb and it 
redu ced T - cell prolifera tion in a dose-de pe ndent manner (Fig 4) . 
As expected , MoAb against ICAM-l had no effect on T -cell 
p roliferation promote d by fLC. In contrast, whe n cLC were use d as 
stim ulators, anti-ICAM-l and anti-ICAM-3 MoAb reduced T-cell 
respo nse to a similar extent. In addition, incubatio n of cLC with 
both anti-ICAM-1 and an ti-ICAM-3 M oA bs had an additive effect 
(92% iJ1hibiti on) (Fig 3). ln line with the lack of expressio n of 
IC AM-2 on LC, MoAbs against this molecul e had n o e ffec t on the 
allostimulatory capacity of e ither fLC or cLC (not shown) [11). 
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FLl-H"-Fl...l - H•1rTtt. -> Fll-H'\FLI ....... tr;.t. --> 
ICAM-1(RR1/1) ICAM-2 (CBR-IC2/2) ICAM-3 (BRIC79) 
FLI-Ii'Fli-Kfolghl. --> Ft.l-+N'Ll~·l~t -> 
Figure 1. Hmnan LC in suspension express ICAM-3 but not ICAM-2. Freshl y iso lntcd epide m1al ce ll suspensions e nri ched for LC were stai ned with 
matched isotype (A), anti-!CAM-3 Mo Abs. 152-20 '11 (1 :400) (B), or T Pl/24 (1 :800) (C), fo llowed by phycoerythrin-conjugnted anti-mouse lg and 
fluoresce in isothiocyanatc-conjugated anti-C Ol a. Abo ut 15% of freshly iso lated epidermal cell s were CO l a + and all of these w e re also ICAM-3 + . D-F show 
72-h cultured LC stained for ICAM-1 (RRl / 1, I 0 J..Lp;/ml) (D). ICAM-2 (CBR-I C2/2, 10 J..Lg / ml) (E), or ICAM- 3 (BIUC79 , 6 .5 J..Lg/ mJ) (F) and fluorescein 
isothiocyanatc- conjuga ted anti-1-fLA-OR .. C ultured LC (I-ILA-DR +) express IC AM-1 and !CAM -3, but no t !CAM-2. 
DISC USSION 
The leukocyte function-associated antigen (LFA)-1 (CD11a/ 
CD18) adhesion molecule plays a pivotal role in cellular in terac-
tions between APC and T lymphocytes [17]. At least three coLulter-
receptors able to bind to LFA-1 have been described, nam ely, 
ICAM-1 (CD54), TCAM-2, and JCAM-3. T hese belong to the Ig 
gene superfim1i1y and bear 5, 2, and 5 lg domains, respectively 
[12-1 5] . Membrane expressio n of I CAMs is heterogeneous am ong 
professional APC and can change according to the activation state 
of the cell. ICAM-1 is expressed by B cells, fres hl y isolated 
peripheral blood monocytes, and DC, w-ith higher levels in the 
latter. In both monocytes and DC, lCA M-1 afte r short-tem1 
culture is up-regulated as compared to ti-eshly isol ated ce!Js [29,30] . 
The tissue distribution of fCAM-2 appears much more restricted 
than that of !CAM-I , with high expressio n on vascular endothe-
lium. Among professional APC, ICAM-2 is present on resting 
monocytes and B cells, but, in contrast to lCAM-1 , m embrane 
ICAM-2 levels do not change substantially upon ac tivation [12). 
DC, including peripheral blood DC, lymph node interdig-itating 
cells, and epiderm al LC do not express lCAM-2 [11 ,12,26). 
ICAM-3 is constitutively expressed by cell s of hemopo ietic lineage, 
the highes t le vels being ex"Pressed on resting monocytes, B cells, 
and DC [14 ,15,31]. Anti-ICAM-3 MoAbs ca n partia!Jy inhibit 
lymphocyte prolife ration in response to mytogens, specifi c antigen , 
or allogene ic stimulator cell s and also limit the allos timulato ry 
fun ction of pe riph eral blood DC (23,3 1 ]. 
Our study demonstrates that LC i11 sit11 and in fresh ly procured 
cell suspensions constitutively express ltig h levels of ICAM-3 and 
that expression is not regulated during LC cul ture. These results arc 
in agreement with those reported for periph eral blood DC by 
Starling ct a/, who found that levels of !CAM-3 remain relatively 
constant followin g cul ture [31]. In terestingly, ICAM-3 expressio n 
is also o nl y marginally depe ndent o n the state of cell activation in 
T lymphocytes [22]. In addition , we have sho wn that lCAM-3 
serves as a re levant co-stimulatory mol ecule in the activation of 
alloreactive T cc iJs by both £LC and cLC. 
£LC and cLC are thought to represent, respectively, mode ls of 
LC i11 sit11 and LC that have been activated and are migra ting to 
regional lymph nodes [28,32] . Human LC i11 s it11 express low levels 
of ICAM-l and LFA-3 (C D58) [8 ,9), which. are, however, re-
moved by the trypsin employed in the preparation of single 
epidermal cell suspensions [11) . In accordance with the limited 
expression of adhesion/costimulato t·y mol ecules, £LC arc weak 
stimulators of T cells. Dlll·ing culture . LC synthesize and then 
progressivel y up-•·egulate m embran e ICAM-1 and LFA-3 [11] . 
Furthermo re, cLC upregula te B7-1 mRNA and express de 1/VJI /l the 
corresponding protein on the cell m embran e [10). We postulate 
that lCAM-3 on £LC may play a very important rol e in the early 
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Figure 2. Freshly isolated and cultured LC express similar amounts 
of membrane ICAM-3. Freshly procured (white !Jars) or 72-h-cultured 
(str;ped bars) LC-enriched epidennal cells were stained for CDla and ICAM-3 
(TP1 124) or 1-lLA-DR and ICAM-3 (TPl/24), as described in Fig 1. Each 
histogr•un represents the difference between the stained sample and its negative 
control, and expresses the number of fluorescence channels obtain ed after 
conversion from a logarithmic to a linear fluorescence intensity. No changes in 
ICAM-3 fluorescence intensity were measured between freshly isolated and 
cultured LC. In contrast, cultured LC upregulatcd HLA-DR and downreb'l.l-
lated CO l a. Data are given as mean cpm :!: SD of three experiments. 
contact between LC an'd T lymphocytes and be critical for initial 
T -cell activation before expression of other co-stimulatory mole-
cules on LC is upregulated. In addition, ICAM-3 is maintained at 
high levels during LC culture and is important to the APC function 
none~~~~~~~~~~~~~~~~~~~~--~ 3E1 (M inlegrin) = 
L243 (HLA·DR) 
BRIC79 (ICAM-3) ., ' RR1 /1 (ICAM·1) _=:~,-~!z~z~::"'' ·:'z:z:~:z:· :z=--.=~~~_<IJ 
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Figure 3. Anti-ICAM-3 MoAbs inhibit the alloautigen-prcscnting 
function of freshly isolated LC (a) and 72-h-cultured LC (b). 
Epidennal cell s e nr iched for LC (3000 LC/well) were incubated with the 
MoAb indicated (45 min, 4°C). After washjng, allogene ic peripheral blood 
mononuclear ce lls deprived of adherent monocytes (150 X 103 /well) were 
added and co- cultu red in flat-bottomed microwell s for 5 d. T he MoAbs 
were added at the following sa turating concentrations: L243, 10 (-Lg/ml; 
BIU C 79 , 6.5 /Lg/ ml; RRl / 1 , CBR.-IC3/3, 20 /Lg/ml); ascites were used at 
1:100-1:200 dilution . Background proliferation ofT ce lls and epidennal 
ce lls alone we re 1520 :!: 596 and 960 ::':: 380, respectively. Data arc given as 
mean cpm :!: SD. Note that cultured LC arc more efricient stimulators of 
allogeneic T cells than freshly jsolated LC. 
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Figure 4. Concentration-dependent inhibition of LC-induced T-
cell proliferation by anti-ICAM-3 MoAb. Conditio ns were as described 
in Fig 3 using 72-h-culturcd LC. e, BIUC79; 0 , isotypc control (SK1 ). 
Data arc given as mean cpm :!: SD. 
of cLC. In these cells lCA.M-3 can cooperate with ICAM-1 or other 
accessory molecules in co-stimulating T cells. cLC become more 
potent stim ulators of allogeneic and syngeneic T cells and acquire 
the ability to activate unprim ed Ag-specific T cells [28,32]. Because 
naive T cells have distinct and more stringent activation require-
m ents tban memory T cells, the functional maturation of LC in 
culture is likely to be dependent on the differential and increased 
expression of m embran e accessory mol ecules [2,33 ,34] . 
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